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Background: Genotyping and massively-parallel sequencing projects result in a vast amount of diploid data that is
only rarely resolved into its constituent haplotypes. It is nevertheless this phased information that is transmitted
from one generation to the next and is most directly associated with biological function and the genetic causes of
biological effects. Despite progress made in genome-wide sequencing and phasing algorithms and methods,
problems assembling (and reconstructing linear haplotypes in) regions of repetitive DNA and structural variation
remain. These dynamic and structurally complex regions are often poorly understood from a sequence point of
view. Regions such as these that are highly similar in their sequence tend to be collapsed onto the genome
assembly. This is turn means downstream determination of the true sequence haplotype in these regions poses a
particular challenge. For structurally complex regions, a more focussed approach to assembling haplotypes may be
required.
Results: In order to investigate reconstruction of spatial information at structurally complex regions, we have used
an emulsion haplotype fusion PCR approach to reproducibly link sequences of up to 1kb in length to allow phasing
of multiple variants from neighbouring loci, using allele-specific PCR and sequencing to detect the phase. By using
emulsion systems linking flanking regions to amplicons within the CNV, this led to the reconstruction of a 59kb
haplotype across the DEFA1A3 CNV in HapMap individuals.
Conclusion: This study has demonstrated a novel use for emulsion haplotype fusion PCR in addressing the issue of
reconstructing structural haplotypes at multiallelic copy variable regions, using the DEFA1A3 locus as an example.
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Establishing phase and resolving combinations of var-
iants situated on the same parental chromosome has
long been considered important in human genetic stud-
ies and approaches to resolve newly sequenced diploid
genomes into their haploid components are gaining
momentum [1-3]. Yet, for the majority of genome
sequences published to date, the fragmentation of DNA
prior to sequencing, coupled with the short read length
of most of the technologies, means that data is provided
as a diploid, unphased read-out, thus losing intrinsic* Correspondence: jess.tyson@nottingham.ac.uk
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distribution, and reproduction in any mediuminformation about which parental chromosome a par-
ticular allele is located on.
The determination of individual haplotypes is valuable
in many areas of research, including (i) association stud-
ies and disease risk, where the analysis of haplotypes is
more powerful than the analysis of single markers alone
[4] and where there may be a haplotype-dependent in-
fluence of variants on risk [5,6], (ii) evolution and popu-
lation genetics [7-9] and (iii) pharmacogenomics [10].
However, despite the fundamental biological importance
of sequence haplotypes, they remain relatively unex-
plored both on a genome-wide and a local scale, due in
large part to the technical difficulties of establishing
phase.
The reconstruction of maternal and paternal haplo-
types over distances longer than a few kilobases is notentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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are included along with the subjects [11-13]. Most com-
monly, haplotypes have been constructed through analysis
of segregation from family data, or inferred using statis-
tical methods. There are numerous statistical approaches
for inferring phase (example algorithms highlighted in
[2,14]), and whilst successful over short distances and fre-
quently used in the post-HapMap era [9,15], these are
not always reliable for regions of low linkage disequilib-
rium (LD) or for rare variants (2). Statistical inference of
phase is particularly difficult for multiallelic copy-variable
regions of the genome. Due to their dynamic nature,
these regions can exhibit low LD with neighbouring
SNPs due to the different haplotypic background on
which any one copy number state can occur. The use of
mate pair reads can permit the reconstruction of haplo-
type information, although often this is only partially suc-
cessful [16]. Experimentally addressing phase may be
approached by physically separating the two parental
chromosomes prior to sequence (and statistical) analysis
by construction of somatic cell hybrids [17], microdissec-
tion [18], microfluidics [19] or chromosome sorting [20].
These methods serve to provide haplotype information
at the genome-wide or chromosome scale, yet they
often rely on specialised instruments and expertise or
are time-consuming and expensive. Other approaches
to generating haplotypes on a genome-wide scale in-
clude cloning- and dilution- based methods that aim to
reduce the complexity of phasing by separating the gen-
omic DNA into pools that contain DNA that is either ma-
ternally or paternally derived, with some of the most
comprehensive molecular haplotypes on a genome-wide
scale produced through the use of fosmid clones [21-24].
Single-molecule sequencing and Long Fragment read
(LFR) technologies could offer a definitive haplotype on a
genome-wide scale, in particular those methods that offer
the possibility of long read lengths and the phasing of het-
erozygous SNPs into long haplotype contigs [25-28].
Whilst such methods are potentially successful in deter-
mining phase of heterozygous SNPs for the majority of
the genome, regions that are variable in structure cannot
be simply reconstructed.
For many studies, including those at structurally com-
plex regions of the genome, the determination of phase
on a more local scale may be more useful and sufficient.
These more focussed molecular approaches include
SNP-specific extraction of targeted genomic regions
[29], recombineering [30], and most frequently, PCR-
based techniques such as long PCR, allele-specific PCR
and a combination of both [31-33], Linking emulsion
PCR [34,35] and Haplotype fusion and ligation haplotyp-
ing [36]. PCR-based techniques provide haplotype data
on a relatively small scale, with the various methods dif-
fering in the way that the phase of variants is resolved.These methods have been valuable in determining the
phase of variants, particularly in the case where haplo-
types are predictive of disease risk or influence gene ex-
pression [34,36].
In emulsion haplotype fusion PCR, fusion PCR is per-
formed to bring two regions of interest, from separate
parts of the same chromosome, together into a single
product. This product corresponds to a condensed
haplotype with the phase of the variants maintained
[35,36]. This reaction is carried out in an emulsion,
which contains millions of aqueous microdroplets sepa-
rated within an oil phase. Each microdroplet thus acts as
an individual PCR microsystem in which amplification
from single molecules of target DNA occurs independ-
ently of the other droplets, with PCR products confined
to their droplet of origin. This method has previously
been used to assay for chromosomal inversions [36,37]
and for haplotyping SNPs [34-36]. Its value lies in the
fact that the distance between the two regions or SNPs
being condensed into a haplotype is theoretically only
limited by the size/quality of the template genomic
DNA. The independent amplification of two short
amplicons, that make a fused product as the reaction
occurs, circumvents issues such as decreasing efficiency
and template-switching errors associated with long PCR
as amplicon length increases [38]. As such, haplotype
fusion PCR will allow determination of haplotypes at
a much greater distance than is accurately possible by
long PCR.
The emulsion haplotype fusion procedure has the po-
tential to be used for any region of the genome to gener-
ate data when familial or computational approaches are
limiting or not possible. We therefore investigated its use
at structurally complex regions which are particularly
hard to analyse [39]. The α-defensin locus is a particularly
challenging locus at which to determine haplotypes. This
locus is a multiallelic copy-variable region located on
chromosome 8p23.1, with a diploid copy number range
of 3–11 in Europeans [40]. The α-defensin genes, which
encode important proteins in the innate immune re-
sponse, are highly expressed in neutrophils and are there-
fore valuable in studying the relationship between gene
copy number and gene expression, and the relationship
between haplotype structure and expression. This struc-
turally complex region consists of a variable number of
19kb full repeats and a 10kb centromeric “partial” repeat
present in one copy per chromosome. The region on the
UCSC assembly (hg18) [41] shows two copies of DEFA1
with one copy of DEFA3 in the most centromeric pos-
ition, but this is only one of many possible structures at
this locus. The observation that each gene locus within
both the full and partial repeats can be occupied by either
DEFA1 or DEFA3 has led to the designation of the locus
as DEFA1A3 [40]. In addition to this, sequence variants
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the locus and further complicate the reconstruction of a
structural haplotype. As for many copy number variants
(CNVs), whilst diploid copy number can be determined
relatively straightforwardly [42,43], positional information
regarding the order of genes, and the sequence variants
contained within them, with the phase of SNPs either
side of the CNV is often overlooked. To address this
issue, we have developed an emulsion haplotype fusion
PCR approach for linking two PCR products each of
up to 1kb in length and examined its use to recon-
struct structural haplotypes at the copy-variable locus
DEFA1A3.Figure 1 Emulsion haplotype fusion PCR. Two loci, approximately 12kb
flanking the copy number variable region containing DEFA1A3 (locus 2). DE
representing the most telomeric repeat, and a grey half arrow representing
shown in A-D: A. Independent amplification occurs at locus 1 and locus 2,
shown in light grey, and is not used in the emulsion but is necessary for th
creating the fusion product. C. Fused product is amplified with F1 and R2.
determination of each haplotype by sequencing.Methods
DNA
DNA samples used to determine the structural haplotypes
at the DEFA1A3 locus were HapMap CEU NA06990,
NA12760 and NA12878. All HapMap samples were
obtained from the Coriell Institute for Medical Research
(http://ccr.coriell.org/).
Haplotype-fusion PCR
Figure 1 illustrates the principle of haplotype fusion
PCR using the telomeric end of the DEFA1A3 CNV as
an example. Two pairs of primers are designed to inde-
pendently amplify regions containing informative SNPsapart are illustrated. Locus 1 corresponds to a single-copy region
FA1A3 repeat units are illustrated as arrows, with a black arrow
another repeat unit present to the right. Amplicons to be fused are
with primers F1, F2’R1 and R2 used in the emulsion. Primer F2 is
e design of the tailed primer B. Locus 1 amplicon primes on locus 2,
D. Allele-specific PCR (ASPCR) with nested primers allows
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gene (locus 2). These primers are denoted F1 and R1
(locus 1 amplicon) and F2 and R2 for the locus 2 ampli-
con. The sequence corresponding to the reverse com-
plement of the forward primer from locus 2 (F2) is
appended to the reverse primer from locus 1 (R1) to
make a tailed primer, F2’R1 [44]. Primers F1, F2’R1 and
R2 are the primers used in the emulsion PCR stage, with
F2’R1 included at a low concentration. In the reaction,
exponential amplification occurs at locus 1 (between
primers F1 and F2’R1) with linear amplification from R2
(locus 2) (Figure 1A). The presence of a tail on primer
F2’R1, which is complementary to F2 (locus 2), results
in a product with the sequence of F2 at the 3’ end. This
enables the top strand of the locus 1 amplicon to prime
the locus 2 amplicon (Figure 1B), thus resulting in the for-
mation of a fused product (Figure 1C). Using F2’R1 at low
concentration ensures this primer becomes exhausted,
such that successive PCR cycles generate copies of the
fused product using primers F1 and R2 which are in the
reaction at a higher concentration. Carrying out the reac-
tion in an emulsion ensures that fusion only occurs be-
tween products originating from the same starting
molecule, i.e., from the same haplotype. Allele-specific
PCR (ASPCR) with nested primers allows determination
of haplotype by sequencing (Figure 1D).
Primer design
Emulsion haplotype fusion systems were designed to link
flanking regions to the first gene in the centromeric
(shown on the right) and telomeric (shown on the left)
repeat positions of the CNV region. Figure 2A illustrates
the concept of designing fusion systems within 2-copy
regions/non-copy variable regions either side of the
CNV to fuse to amplicons within the CNV and thus pro-
vide a structural haplotype for either end of the CNV.
Centromeric emulsion PCR
Information on the centromeric flanking region and
associated informative SNPs was obtained by sequencing
(Holly Black, personal communication). For linking
these SNPs to the gene in the most centromeric repeat
(Figure 2B), individual primers were designed to amplify
a 582bp amplicon from DEFA1A3 and a 227bp product
encompassing rs4300027 (Chr8:6867985) and rs4512398
(Chr8:6868004) (UCSC genome browser, March 2006
[41]). DEFA1A3 sequence variants were identified by
PCR and sequencing of the 582bp amplicon (see
Additional file 1: Table S1 for details and location of
DEFA1A3 sequence variants).
Telomeric emulsion PCR
Information on telomeric flanking SNPs was obtained by
downloading phased haplotype data (HapMap, release#24) for a 10.7kb region (chr8:6801434–6812149, UCSC
genome browser, March 2006 [41]) telomeric to the start
of the first full repeat. Within this 10.7kb region, two
different PCR amplicons were designed to incorporate at
least 2 informative variants in the HapMap CEPH indivi-
duals used in this study. For NA12760 and NA06990,
telomeric emulsion system 1 was used to establish hap-
lotypes for the telomeric end of the copy-variable region
(Figure 2B). A 771bp PCR product was designed to in-
clude SNPs rs2738046 (Chr8:6810952), rs2738045
(Chr8:6810978) and rs2702910 (Chr8:6811301) telomeric
to the copy variable region. For NA12878, telomeric
emulsion system 2 was used to establish telomeric
haplotypes. A 376bp PCR product designed to in-
clude SNPs rs56342413 (Chr8:6808918) and rs2738058
(Chr8:6809027), heterozygous in NA12878, telomeric to
the copy variable region. Both products were fused to a
582bp amplicon from DEFA1A3.
For the second round of amplification, once the emul-
sion has been disrupted, both nested and allele-specific
primers were designed to amplify and characterise
the fused products generated in the emulsion (see
Additional file 1: Table S2 for details). Combining data
from both emulsion systems allows a structural haplo-
type to be assembled (Figure 2C).
All primers were manufactured by Invitrogen or IDT
with the desalt purification option (See Table 1 for pri-
mer sequences).
PCR
For all emulsion experiments, PCR conditions were estab-
lished in solution prior to being carried out in an emulsion.
PCRs were prepared in a total aqueous volume of 100 μl,
containing 1x Phusion GC buffer (Finnzymes), 200 μM
each dNTP (NEB), 1 μM primer F1, 1 μM primer R2,
25 nM primer F2’R1, 200 ng genomic DNA and 14 units
Phusion DNA polymerase (Finnzymes). 10 μl aqueous
phase was added every 5 to 10 seconds to 200 μl oil phase
(4.5% vol/vol Span 80, 0.4% vol/vol Tween 80 and 0.05%
Triton X-100 dissolved in light mineral oil (Sigma)) in a
2 ml cryo-vial while stirring at 1000 rpm for a total of
5 minutes as previously described by Turner et al. [44].
The average diameter of the aqueous droplets was about
5 μm, as ascertained by microscopy (data not shown).
100 μl of aqueous/oil mixture was transferred to 0.5 ml
PCR tubes and first-round amplification carried out at 98°C
for 30 seconds and 40 cycles of 98°C for 10 seconds, 70°C
for 30 seconds and 72°C for 30 seconds. This was followed
by 72°C for 5 minutes and a 4°C hold. 100 μl of the original
aqueous/oil mixture was not subjected to first-round ther-
mal cycling, and retained as a non-cycle emulsion control
at the second stage of PCR. Emulsions were disrupted as
soon as possible after the final cycle of the PCR by adding
200 μl hexane (Sigma) directly to the PCR tube, vortexing
Figure 2 Emulsion haplotype fusion PCR for determination of structural haplotypes. Two emulsion haplotype fusion systems are used to
provide spatial information either side of the CNV as shown by the two large arrows (A). Amplicons are designed to fuse non copy-variable
flanking regions to the gene in the first repeat, from either the telomeric or centromeric directions independently (B). DEFA1A3 repeat units are
illustrated as arrows, with a black arrow representing the most telomeric or centromeric repeat, and a grey half arrow representing another
repeat unit present to the right (for the telomeric system) or left (for the centromeric system). Amplicons to be fused and the final haplotypes are
shown as filled rectangles. Primers used in the emulsion are shown. Integration of the telomeric and centromeric sequence data is used to
determine the structural haplotype across the CNV (C). This is shown for NA06990.
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After removal of the oil phase, the hexane extraction was
repeated twice more. The non-cycle emulsion control, i.e.
100 μl of the original aqueous/oil mixture that had not
undergone the first PCR, was extracted alongside the
emulsion PCRs and used in the secondary PCR as a con-
trol. Before proceeding to the secondary PCR (or storing
at −20°C), uncovered tubes were left for 10 minutes in the
fume hood to allow any remaining hexane to evaporate.Allele-specific PCR (ASPCR) and sequencing of condensed
haplotypes
After hexane extraction, the primary (fusion) products
in the remaining aqueous phase were diluted 10-fold
with dH2O for the second round of amplification. At this
stage extracted aqueous phase from the non-cycle emul-
sion and 10 ng of genomic DNA were included as
two additional controls. A lack of amplification derived
from these controls demonstrates that the product is
Table 1 Primers used in the first round of emulsion haplotype fusion PCR
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conditions used do not permit the formation of the
fused product in the absence of these steps. 1 μl of the
1:10 dilution was amplified in a total volume of 20 μl
containing 1x NH4 reaction buffer (Bioline), 2 mM
MgCl2, 200 μM each dNTP, 500 nM of each primer F1
or F1N and R2N and 1 unit of Taq DNA polymerase
(Bioline). Amplification of this secondary product was
carried out for 30 cycles of 95°C for 30 seconds, primer-
specific annealing step 1 minute and 72°C for 1 minute.
Annealing temperatures and primers used in the second
round of PCR are detailed in Additional file 1: Table S2.
PCR conditions for allele-specific primers were estab-
lished using control DNA samples homozygous for each
genotype.
PCR products were purified using AMPure (Agen-
court) following the manufacturer’s protocol and 20-
30 ng sequenced, in both the forward and reverse direction,
using 0.5 μl BigDye Terminator v3.1 mix and 3.5 μl 5x Big-
Dye sequencing buffer (Applied Biosystems) with standard
cycle sequencing conditions. Extension products were puri-
fied using CleanSEQ (Agencourt) following the manufac-
turer’s protocol.
Results and discussion
The lengths of the amplicons attempted in previously
published emulsion fusion experiments have been rela-
tively short, and in turn have limited the amount of SNP
information that can be assembled into haplotypes
[35,36]. To be able to use emulsion haplotype fusion
PCR to establish structural haplotypes, it was necessary
both to increase the length of the amplicons fused in the
emulsion (to allow the phasing of more SNPs simultan-
eously) and to simplify post-fusion detection of the
phase. Conditions were established such that amplicons
of up to 1kb in length, (and hence a 2kb fused hap-
lotype) could be reliably and reproducibly achieved. In
contrast to previously published methods of emulsion
fusion PCR [34,36], PCR and sequencing were intro-
duced to detect the resulting phase. Once established ina test system, the aim was to investigate whether this
method could be used to reconstruct structural haplo-
types at the multiallelic copy-variable locus, DEFA1A3.
Using the CCL3L1/CCL4L1 locus as a test system, pre-
liminary work explored aspects of the emulsion haplo-
type fusion PCR that were important for its reliability
and reproducibility (see Additional files 1 and 2). The
effects of the average droplet size of the aqueous com-
partment in the emulsion and concentration of primers
in the reaction were explored, in particular the concen-
tration of the fusion primer F2’R1, where 25 nM gave
the best results. Amplification of the fused product was
only observed after two rounds of PCR; the first round,
which is carried out in the emulsion, and a second, once
the emulsion has been disrupted. It is at this second
stage that the use of at least one nested primer ensured
a specific secondary product. In our experience, a pre-
dominance of unwanted products of incorrect size is
observed if the same pair of primers is used in both the
emulsion PCR stage and the secondary amplification. An
additional control was introduced, which consisted of
retaining a 100 μl aliquot of each emulsion that was not
amplified in the first round of PCR. The aqueous phase
for this control was extracted as for the emulsion PCR
product, and resultant aqueous phase amplified only in
the secondary PCR. This resulted in the absence of a
PCR product thus demonstrating that amplification
depended on the emulsion PCR stage.
Having demonstrated the successful fusion of two 1kb
amplicons in an emulsion, and direct sequencing of the
product to confirm the maintenance of phase using the
known relationship of SNPs in the CCL3L1/CCL4L1 test
system (see Additional files 1 and 2), the method was
applied to the DEFA1A3 locus. As is the case for many
multiallelic copy-variable regions, multiple levels of
complexity exist at the DEFA1A3 region in the form of
copy number variation, gene identity and sequence vari-
ation [40]. We wanted to establish whether emulsion
haplotype fusion PCR could be used to reconstruct hap-
lotypes and provide positional information about the
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across this copy-variable region. For the samples studied,
diploid copy number and number of DEFA1 and DEFA3
genes was determined by paralogue ratio test (PRT)
(manuscript in preparation) and allele-ratio analysis re-
spectively [40].
Initial work centred on a 3-copy individual, NA06990,
for which haplotype copy number and ratio of DEFA1:
DEFA3 genes had previously been established through
segregation (Figure 2C; Fayeza Khan, personal commu-
nication). Therefore, prior to this study, it was known that
NA06990 has a 2-copy haplotype consisting of 2 copies of
DEFA1, and a 1-copy haplotype with a single copy of
DEFA3 occupying the centromeric partial repeat loca-
tion. This sample served as a test of whether emulsion
haplotype fusion PCR could reconstruct linear haplotypes
faithfully.
In order to build up the structural haplotype, sequence
variants within the gene were first identified by (non-
emulsion) PCR and sequencing using the centromeric
emulsion primers F1 to F2’R1. Sequence variants and
browser coordinates are shown in Additional file 1:
Table S1. This provided information on the number and
nature of sequence variants present in the three copies
of DEFA1A3 in this individual, but not which combina-
tions of variants were found in the same gene or where
each gene was located. Heterozygosity for flanking SNPs
was determined by PCR and restriction enzyme digest
or by using HapMap phased genotype data (release #24).
In order to build up a haplotype across the CNV, the
nature of the end most repeats were defined first. Haplo-
types for the centromeric end of the CNV region were
established using the centromeric emulsion system
(Figure 2B). This system determines the phase of flank-
ing SNPs rs4300027 and rs4512398 with the gene in the
centromeric (partial) repeat location. The condensed
haplotypes were generated and the phase of flanking var-
iants and nature of the gene in this position established
by both non-discriminatory and allele-specific PCR and
sequencing. Sequencing of the fused product with a
non-discriminatory primer (CenR2N), a reverse primer
within the single-copy flanking amplicon, which ampli-
fies both condensed chromosomes, revealed eight het-
erozygous positions within the DEFA1A3 portion of the
fused product (including variant 1, a G/T single nucleo-
tide variant that distinguishes DEFA1 from DEFA3). This
demonstrated that the centromeric partial repeats consist
of one copy of DEFA1 and one copy of DEFA3 (denoted
repeat 2 and repeat 3 respectively in Figures 2C and 3).
Allele-specific PCR and sequencing was then used to
establish the centromeric haplotypes as illustrated in
Figure 3A.
Interestingly, as illustrated in Figure 3B, two of the
eight variant positions (variant numbers 2 and 3)remained mixed after allele-specific PCR and sequencing
with primer T at rs4512398, albeit with the secondary
peak appearing at lower representation (Figure 3B:
centromeric emulsion product). Sequencing of the entire
allele-specific fused product showed a G at variant pos-
ition 1, illustrating that the product was due to the fu-
sion of the right-hand amplicon (containing centromeric
flanking SNPs) to an additional copy of DEFA1 and not
DEFA3, and therefore not due to anomalous fusions
appearing within the emulsion. F1 and R1 primers for
the centromeric emulsion system (and also F2 and R2 of
the telomeric system) are designed to amplify a copy-
variable gene. The distance from the flanking SNPs
to the next copy of DEFA1 in repeat position 1
(chr8:6841698–6844134) (Figure 3) is 26kb. Given the
physical distances involved and the expected average size
of DNA in solution, this prompted investigation of
whether the minor product represented fusion of the
centromeric flanking amplicon to the copy of DEFA1 in
the next repeat (repeat 1). There was no mixed sequence
for the other 6 heterozygous positions in this sequence
and no mixed positions observed in the allele-specific
sequence with primer C at rs4512398.
The genes at the telomeric end of the CNV were
determined using the telomeric emulsion system. Se-
quence analysis showed that G at rs2702910 is on the
same chromosome as a copy of DEFA1 and A at rs2702910
is on the same chromosome as a copy of DEFA3. Examin-
ation of the allele-specific sequencing of the telomeric
emulsion fused product using primer G at rs2702910
showed reciprocal mixed positions to the ones seen from
the centromeric direction (Figure 3B: telomeric emulsion
product). This provided confirmatory evidence that the se-
quence observed at lower representation on the trace is that
of a second copy of the gene on the same chromosome.
Integration of sequence information from both the
centromeric and telomeric emulsion systems allows the
mapping of individual genes and associated repeat-
specific sequence variants, and the phasing of these with
flanking SNPs. Using emulsion haplotype fusion PCR,
haplotypes could be reconstructed across the 38kb and
19kb of the 2-copy and 1-copy repeat unit respectively,
as shown in Figure 3B. For the emulsion systems where
primers are designed to amplify all copies of DEFA1A3
present in an individual, we need to be sure that the
major product is the result of the fusion of the flanking
SNPs to the gene in the repeat unit next to the flanking
SNPs. The success of the emulsion fusion PCR method has
a close relationship with the average fragment size of the
genomic DNA, because it depends on the flanking DNA
and at least the first repeat unit being present on the same
DNA molecule. However, because of randomly-positioned
double-stranded DNA breaks, there is a decreasing
probability that the second and subsequent repeats
Figure 3 Centromeric haplotype for NA06990. Panel A shows the haplotypes for the most centromeric repeats for NA06990. Constituent
haplotypes are resolved using allele-specific primers, specific to either the T or C at rs4512398. The phase of sequence variants within the gene
(numbers 2 to 8; see additional Table 1) are shown boxed, from variant number 2 on the left to number 8 on the right. Variant positions 5 and 6
are shown in bold. The corresponding base in the sequence trace is shown boxed. Examination of the sequence at variant position 1 (data not
shown) illustrated that T at rs4512398 is on the same chromosome as a copy of DEFA1 and C at rs4512398 is in cis with a copy of DEFA3. Panel B
illustrates some of the sequence information used to reconstruct the full haplotypes in this individual. For the centromeric emulsion product,
allele-specific sequence using primer T at rs4512398 shows mixed positions at variant positions 2 and 3. At variant position 2, C is observed as the
major peak, and A the minor peak and at variant position 3, C is the major peak with T as the minor peak. Sequencing of the entire fused
product showed a C at variant position 1, which defines a copy of DEFA1 thereby excluding inappropriate fusion with Repeat 3 on the other
haplotype, which carries a copy of DEFA3. Sequencing from the telomeric direction (telomeric emulsion product) showed precisely reciprocal
mixed positions (with A at variant 2 being the major product and C the minor). This is consistent with a major contribution from Repeat 1 and a
minor contribution from Repeat 2. This reciprocity allowed reconstruction of this 2-copy haplotype. DEFA1A3 repeat units are illustrated as arrows.
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the second and third most repeats would therefore
be predicted to happen more infrequently than fusion
to the first, and hence these are observed as minor
products. This observation can be further supportedusing samples such as NA06990 where the nature of
the centromeric genes can be verified by long PCR
or segregation.
The approach of integrating allele-specific sequence
data from both telomeric and centromeric emulsion
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was then investigated in NA12760 and NA12878, two 5-
copy individuals of unknown haplotype composition.
Whilst the diploid copy number of these HapMap indi-
viduals had been established by PRT, no information on
the haplotype copy number or haplotype composition
was available. Information already determined concern-
ing the ratio of number of copies of DEFA1 to DEFA3
was not used to inform inferences, but was subsequently
checked for consistency.
Sequence variants within the portion of DEFA1A3 to be
fused to flanking SNPs were identified in NA12760 and
NA12878 by PCR and sequencing. In order to build up
the structural haplotype for these 5-copy individuals, the
nature of the most telomeric and centromeric repeats wasFigure 4 The haplotypes defined by emulsion-fusion PCR at the DEFA
NA12878 (panel B). Haplotype copy number and the phase of SNPs with
information from the telomeric and centromeric emulsion systems that link
Panel A illustrates some of the sequence data used to define the structural
DEFA3 (T), are shown for the four end repeats for NA12670, for example C
rs2738046 is on the same chromosome as a copy of DEFA3. Mixed position
provide spatial information regarding the five copies present in these indiv
within each copy are shown. The phase of gene-specific sequence variants
variant number 2 on the left to number 8 on the right. Panel B shows theestablished by emulsion PCR and allele-specific sequen-
cing from both centromeric and telomeric emulsion sys-
tems respectively. Figure 4A shows portions of the
sequence trace corresponding to the most telomeric and
centromeric genes in the CNV using NA12760 as an
example. Having established, in a sample of known haplo-
type composition, that mixed positions in the allele-
specific sequence data were due to fusion of the flanking
amplicon to the gene in the next repeat on the same
chromosome, the sequence data for both 5-copy indi-
viduals was examined at the 8 variant positions within the
gene. This is illustrated with variants 2 and 6 for the
centromeric haplotype (see Figure 4A). Positions such as
variant 4, which differs between the 2 haplotypes, but only
shows a G in the allele-specific sequencing allows us to1A3 locus on 8p23.1 are shown for NA12760 (panel A) and
in the genes across this CNV were established by combining sequence
SNPs flanking the CNV to the copy-variable genes in the repeat array.
haplotype. Sequence of variant 1, which distinguishes DEFA1 (G) and
at rs2738046 is on the same chromosome as a copy of DEFA1 and A at
s (variants 2 and 6) and non-mixed positions (variant 4) are used
iduals. The identity and position of the gene and sequence variants
(numbers 2 to 8; see additional Table 1) are shown boxed, from
final structural haplotype for NA12878.
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observed, is from the next gene on the same chromosome
and not from the other haplotype. Combining allele-
specific sequence data from both emulsion systems linking
flanking regions of the CNV to sequence within the CNV
demonstrated that both NA12760 and NA12878 are com-
posed of a 2-copy and a 3-copy haplotype as illustrated in
Figure 4A and 4B respectively, and has provided spatial in-
formation regarding the location of each copy of the gene
and its associated variants. The results obtained were sup-
ported by the diploid DEFA1:DEFA3 ratio. For a 3-copy al-
lele consisting of two copy-variable 19kb full repeats and
one 10kb centromeric partial repeat, this approach recon-
structs a 59kb haplotype across the copy-variable locus.
Whilst diploid copy number was known, no prior know-
ledge regarding haplotype copy number or composition
was required, with data on flanking regions and the detec-
tion of phase obtained in a simple and straightforward
manner.Conclusions
The emulsion fusion procedure described here has suc-
cessfully fused two PCR products up to 1kb in length to
determine the haplotype of variants and to reconstruct
linear haplotypes across approximately 59kb at a copy-
variable locus. This work has demonstrated a novel use
for emulsion haplotype fusion PCR to establish struc-
tural haplotypes at complex genomic regions.
Using emulsion haplotype fusion PCR we have defined
the haplotypes for the copy-variable DEFA1A3 locus in
three HapMap individuals, NA06990, NA12760 and
NA12878. The diploid sequence of NA12878 has been ex-
tensively analysed as part of the 1000 genome project [45],
and most recently whole genome fosmid data has been
generated to resolve the diploid sequence information into
phase haplotypes [23]. Yet despite this “gold standard” ap-
proach to genome-wide definition of haplotypes, it has
not yet allowed simple reconstruction of haplotypes at
multiallelic copy-variable regions, such as the DEFA1A3
locus (M. Hoehe, personal communication). Copy variable
regions are often studied from a diploid copy number per-
spective with positional information and sequence variants
within each copy repeat neglected, primarily due to the
difficulty in resolving sequence relationships for these
regions. These regions are often poorly understood espe-
cially in terms of dissecting diploid copy number states
into haploid allelic contributions, yet the position of each
of these genes and their local sequence variants within the
array may have an effect on expression [46]. Determin-
ation of the combinations of sequence variants within
copy-variable repeat units can, in parallel, provide valuable
information on the evolutionary history of these regions
by clarifying true structural relationships between alleles.Previous use of haplotype emulsion fusion PCR empha-
sised its use in genotyping two or three specific SNPs
across a distance greater than amenable to long PCR
[34,36]. In this study, emulsion haplotype fusion PCR was
used to build a structural haplotype across a complex and
structurally variable region using the DEFA1A3 locus as
an example. Amplicons telomeric and centromeric to the
CNV were designed to fuse to an amplicon within the
CNV thus providing haplotypes at each end of the CNV.
Integration of sequence information was then used to re-
construct the haplotype. For many DNA samples studied
in the laboratory, information on diploid copy number of
a copy-variable gene can be straightforwardly ascertained.
In addition, if family members are available haplotype
copy number can be established through analysis of segre-
gation. What remains to be established is positional infor-
mation relating to the genes and any associated variants.
To answer this, allele-specific sequence data from two
emulsion fusion PCR systems, one telomeric to the CNV
and the other centromeric to the CNV were used to define
which gene and associated variants resided in the end re-
peat positions. Mixed positions in the allele-specific prod-
uct provided evidence of fusion of the flanking amplicon
to the amplicon from the gene of the second repeat on the
same chromosome. Our experience with samples of
known haplotype suggests that products detected as
minor peaks on haplotype-specific sequence traces can in-
dicate the sequence of the second repeat unit adjacent to
the flanking product. In the case of the two-copy haplo-
types observed in this study, data from the centromeric
emulsion can complement that from the telomeric
emulsion- i.e., from the centromeric direction, the fusion
of the gene (and variants) in the centromeric partial repeat
is the major product with the next gene on the same
chromosome (a further 19kb away) being the minor prod-
uct, and vice versa from the telomeric direction. This
work led to the construction of a structural haplotype of
59kb across the CNV, in which the relative positions of
different gene sequence variants are defined. In the case of
NA12878, where the 3-copy haplotype contained identical
copies of DEFA1, haplotype structure was supported by
total diploid CN, ratio of DEFA1:DEFA3 and using infor-
mation obtained for the 2-copy haplotype.
The ability to fuse amplicons of 1kb and longer means
that more SNPs can be phased simultaneously. Not only
is this particularly important if not all variants within
the copy-variable region are informative for all samples
or all repeat units, but the longer amplicon derived from
the single-copy flanking region can also be designed to
include multiple SNPs that can act as internal controls
for checking allele-specificity of the PCR. For any locus,
emulsion systems can be easily and straightforwardly
designed with no restriction on primer position, to pro-
duce sequence data that is straightforward to interpret.
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http://www.biomedcentral.com/1471-2164/13/693Whilst this study has established a structural haplotype
for a chromosome with 3 copies of DEFA1A3, this pro-
cedure is not necessarily limited to low copy samples. If
required, repeat-specific variants can be exploited in an
emulsion system to “walk” between repeats across a
higher-copy haplotype.
Emulsion haplotype-fusion is a relatively simple and
versatile procedure for molecular haplotyping, but has
had a limited uptake in practice. Previous protocols have
used a variety of downstream methods to determine the
haplotype. For example, Turner et al. used a bridging
oligonucleotide, adjacent to the two SNPs under interro-
gation, to detect the haplotype in the fused product made
in the emulsion PCR stage. Specific oligos of different
length were then used to target each possible base of the
SNP and ligated to the common bridging oligo. After
amplification with universal primers, each haplotype had a
characteristic size and as such was determined by capillary
electrophoresis. Whilst successful and applicable to high-
throughput haplotype determination, the scheme imposes
limits on the position of the primers and the number of
SNPs that can be examined. The constraints imposed by
the post-fusion detection of the haplotype in previously
published approaches, for example on the position of pri-
mers and bridging oligonucleotides, the use of specialist
equipment (e.g. fluorescence microscope for bead haplo-
typing) or modified oligonucleotides [34-36] has in turn
meant that only small amplicons have been amplified and
subsequently condensed into a haplotype, and that infor-
mation from very few SNPs has been captured [34,36].
These post-fusion detection methods may have been
adopted because previous methods were not capable of re-
liably generating fused product of sufficient purity to ana-
lyse by direct sequencing, and if so this limitation seems
to have been removed by our adoption of nested primers
in the secondary PCR. Building on the original principle
of fusion PCR, the procedure developed here is charac-
terised by nesting of the secondary product and a simple
post-fusion detection of phase by direct sequencing. Our
approach with larger amplicons fused in an emulsion
allows a greater number of SNPs to be examined simul-
taneously and more flexibly in a single reaction with no
restriction on primer position. Creating fused products
from elements up to about 50kb apart by these methods
would not require special treatment of genomic DNA,
and so could be easily applied to the kinds of genomic
DNA preparation generally held in banks of clinically-
derived samples.
The development of next-generation sequencing tech-
nologies has allowed the sequencing of individual gen-
omes to become a reality, documenting the true extent
of variation contained within them both with respect to
sequence and structural variation. Despite this progress,
there remains the need to establish phase of variants,including the haplotypes at CNVs, in order to provide a
complete assessment of any individual’s genome. With-
out approaches to reconstruct spatial information in
human genome sequences, our picture of the genome
will remain collapsed and incomplete.
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